Cargando…

Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer

BACKGROUND: Hypoxia-inducible factor 1 (HIF-1) is a master transcriptional regulator of genes regulating oxygen homeostasis. The HIF-1 protein is composed of two HIF-1α and HIF-1β/aryl hydrocarbon receptor nuclear translocator (ARNT) subunits. The prognostic relevance of HIF-1α protein overexpressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Dales, Jean-Philippe, Beaufils, Nathalie, Silvy, Monique, Picard, Christophe, Pauly, Vanessa, Pradel, Vincent, Formisano-Tréziny, Christine, Bonnier, Pascal, Giusiano, Sophie, Charpin, Colette, Gabert, Jean
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917392/
https://www.ncbi.nlm.nih.gov/pubmed/20624301
http://dx.doi.org/10.1186/1741-7015-8-44
_version_ 1782185063246462976
author Dales, Jean-Philippe
Beaufils, Nathalie
Silvy, Monique
Picard, Christophe
Pauly, Vanessa
Pradel, Vincent
Formisano-Tréziny, Christine
Bonnier, Pascal
Giusiano, Sophie
Charpin, Colette
Gabert, Jean
author_facet Dales, Jean-Philippe
Beaufils, Nathalie
Silvy, Monique
Picard, Christophe
Pauly, Vanessa
Pradel, Vincent
Formisano-Tréziny, Christine
Bonnier, Pascal
Giusiano, Sophie
Charpin, Colette
Gabert, Jean
author_sort Dales, Jean-Philippe
collection PubMed
description BACKGROUND: Hypoxia-inducible factor 1 (HIF-1) is a master transcriptional regulator of genes regulating oxygen homeostasis. The HIF-1 protein is composed of two HIF-1α and HIF-1β/aryl hydrocarbon receptor nuclear translocator (ARNT) subunits. The prognostic relevance of HIF-1α protein overexpression has been shown in breast cancer. The impact of HIF-1α alternative splice variant expression on breast cancer prognosis in terms of metastasis risk is not well known. METHODS: Using real-time quantitative reverse transcription PCR assays, we measured mRNA concentrations of total HIF-1α and 4 variants in breast tissue specimens in a series of 29 normal tissues or benign lesions (normal/benign) and 53 primary carcinomas. In breast cancers HIF-1α splice variant levels were compared to clinicopathological parameters including tumour microvessel density and metastasis-free survival. RESULTS: HIF-1α isoforms containing a three base pairs TAG insertion between exon 1 and exon 2 (designated HIF-1α(TAG)) and HIF-1α(736 )mRNAs were found expressed at higher levels in oestrogen receptor (OR)-negative carcinomas compared to normal/benign tissues (P = 0.009 and P = 0.004 respectively). In breast carcinoma specimens, lymph node status was significantly associated with HIF-1α(TAG )mRNA levels (P = 0.037). Significant statistical association was found between tumour grade and HIF-1α(TAG )(P = 0.048), and total HIF-1α (P = 0.048) mRNA levels. HIF-1α(TAG )mRNA levels were also inversely correlated with both oestrogen and progesterone receptor status (P = 0.005 and P = 0.033 respectively). Univariate analysis showed that high HIF-1α(TAG )mRNA levels correlated with shortened metastasis free survival (P = 0.01). CONCLUSIONS: Our results show for the first time that mRNA expression of a HIF-1α(TAG )splice variant reflects a stage of breast cancer progression and is associated with a worse prognosis. See commentary: http://www.biomedcentral.com/1741-7015/8/45
format Text
id pubmed-2917392
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29173922010-08-07 Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer Dales, Jean-Philippe Beaufils, Nathalie Silvy, Monique Picard, Christophe Pauly, Vanessa Pradel, Vincent Formisano-Tréziny, Christine Bonnier, Pascal Giusiano, Sophie Charpin, Colette Gabert, Jean BMC Med Research Article BACKGROUND: Hypoxia-inducible factor 1 (HIF-1) is a master transcriptional regulator of genes regulating oxygen homeostasis. The HIF-1 protein is composed of two HIF-1α and HIF-1β/aryl hydrocarbon receptor nuclear translocator (ARNT) subunits. The prognostic relevance of HIF-1α protein overexpression has been shown in breast cancer. The impact of HIF-1α alternative splice variant expression on breast cancer prognosis in terms of metastasis risk is not well known. METHODS: Using real-time quantitative reverse transcription PCR assays, we measured mRNA concentrations of total HIF-1α and 4 variants in breast tissue specimens in a series of 29 normal tissues or benign lesions (normal/benign) and 53 primary carcinomas. In breast cancers HIF-1α splice variant levels were compared to clinicopathological parameters including tumour microvessel density and metastasis-free survival. RESULTS: HIF-1α isoforms containing a three base pairs TAG insertion between exon 1 and exon 2 (designated HIF-1α(TAG)) and HIF-1α(736 )mRNAs were found expressed at higher levels in oestrogen receptor (OR)-negative carcinomas compared to normal/benign tissues (P = 0.009 and P = 0.004 respectively). In breast carcinoma specimens, lymph node status was significantly associated with HIF-1α(TAG )mRNA levels (P = 0.037). Significant statistical association was found between tumour grade and HIF-1α(TAG )(P = 0.048), and total HIF-1α (P = 0.048) mRNA levels. HIF-1α(TAG )mRNA levels were also inversely correlated with both oestrogen and progesterone receptor status (P = 0.005 and P = 0.033 respectively). Univariate analysis showed that high HIF-1α(TAG )mRNA levels correlated with shortened metastasis free survival (P = 0.01). CONCLUSIONS: Our results show for the first time that mRNA expression of a HIF-1α(TAG )splice variant reflects a stage of breast cancer progression and is associated with a worse prognosis. See commentary: http://www.biomedcentral.com/1741-7015/8/45 BioMed Central 2010-07-12 /pmc/articles/PMC2917392/ /pubmed/20624301 http://dx.doi.org/10.1186/1741-7015-8-44 Text en Copyright ©2010 Dales et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dales, Jean-Philippe
Beaufils, Nathalie
Silvy, Monique
Picard, Christophe
Pauly, Vanessa
Pradel, Vincent
Formisano-Tréziny, Christine
Bonnier, Pascal
Giusiano, Sophie
Charpin, Colette
Gabert, Jean
Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
title Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
title_full Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
title_fullStr Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
title_full_unstemmed Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
title_short Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
title_sort hypoxia inducible factor 1α gene (hif-1α) splice variants: potential prognostic biomarkers in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917392/
https://www.ncbi.nlm.nih.gov/pubmed/20624301
http://dx.doi.org/10.1186/1741-7015-8-44
work_keys_str_mv AT dalesjeanphilippe hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT beaufilsnathalie hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT silvymonique hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT picardchristophe hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT paulyvanessa hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT pradelvincent hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT formisanotrezinychristine hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT bonnierpascal hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT giusianosophie hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT charpincolette hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer
AT gabertjean hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer